Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 348
Filter
1.
J Hosp Infect ; 129: 181-188, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35820556

ABSTRACT

BACKGROUND: A 1% potassium peroxymonosulphate-based environmental disinfectant (PPED) produces sodium hypochlorite when combined with sodium chloride, which functions as a disinfectant. However, little is known about the impact of hospital cleaning with PPED on hospital-onset Clostridioides difficile infection (HO-CDI). AIM: To reduce HO-CDI, we promoted antimicrobial stewardship and hospital ward cleaning with PPED: this study was conducted to evaluate their impact. METHODS: We began a promotion of post-prescription review with feedback for broad-spectrum antimicrobials and hospital ward cleaning with PPED. We reviewed the ratio of HO-CDI, PPED consumption, and days of therapy (DOT) of broad-spectrum antimicrobials between July 2014 and March 2018, dividing this time into the pre-promotion (July 2014 to June 2015) and post-promotion periods (July 2015 to March 2018). FINDINGS: Using interrupted time series analysis, an immediate significant change in HO-CDI was observed after intervention (P=0.03), although a downward trend was not observed over this period (P=0.19). Trends in PPED consumption significantly changed over this period (P=0.02). DOT of carbapenems decreased immediately after the intervention began (P<0.01). A Poisson regression analysis showed that PPED consumption and DOT of carbapenems were independent factors affecting HO-CDI (P=0.039 and 0.016, respectively). CONCLUSION: We revealed that DOT of carbapenems and use of PPED were associated with the HO-CDI ratio and that both interventions reduced the rate of HO-CDI. This is the first report on the impact of hospital ward cleaning with PPED on the reduction of HO-CDI.


Subject(s)
Anti-Infective Agents , Antimicrobial Stewardship , Clostridioides difficile , Clostridium Infections , Cross Infection , Disinfectants , Humans , Potassium , Sodium Hypochlorite , Sodium Chloride , Cross Infection/prevention & control , Clostridium Infections/prevention & control , Hospitals , Carbapenems
2.
AJNR Am J Neuroradiol ; 43(6): 893-898, 2022 06.
Article in English | MEDLINE | ID: mdl-35550283

ABSTRACT

BACKGROUND AND PURPOSE: In patients with ischemic stroke, DWI lesions can occasionally be reversed by reperfusion therapy. This study aimed to ascertain the relationship between ADC levels and DWI reversal in patients with acute ischemic stroke who underwent recanalization treatment. MATERIALS AND METHODS: We conducted a retrospective cohort study in patients with acute ischemic stroke who underwent endovascular mechanical thrombectomy with successful recanalization between April 2017 and March 2021. DWI reversal was assessed through follow-up MR imaging approximately 24 hours after treatment. RESULTS: In total, 118 patients were included. DWI reversal was confirmed in 42 patients. The ADC level in patients with reversal was significantly higher than that in patients without reversal. Eighty-three percent of patients with DWI reversal areas had mean ADC levels of ≥520 × 10-6 mm2/s, and 71% of patients without DWI reversal areas had mean ADC levels of <520 × 10-6 mm2/s. The mean ADC threshold was 520 × 10-6 mm2/s with a sensitivity and specificity of 71% and 83%, respectively. In multivariate analysis, the mean ADC level (OR, 1.023; 95% CI, 1.013-1.033; P < .0001) was independently associated with DWI reversal. Patients with DWI reversal areas had earlier neurologic improvement (NIHSS at 7 days) than patients without reversal areas (P < .0001). CONCLUSIONS: In acute ischemic stroke, the ADC value is independently associated with DWI reversal. Lesions with a mean ADC of ≥520 × 10-6 mm2/s are salvageable by mechanical thrombectomy, and DWI reversal areas regain neurologic function. The ADC value is easily assessed and is a useful tool to predict viable lesions.


Subject(s)
Brain Ischemia , Ischemic Stroke , Stroke , Brain Ischemia/complications , Brain Ischemia/diagnostic imaging , Brain Ischemia/surgery , Diffusion Magnetic Resonance Imaging , Humans , Ischemic Stroke/diagnostic imaging , Ischemic Stroke/surgery , Retrospective Studies , Stroke/complications , Stroke/diagnostic imaging , Stroke/surgery , Thrombectomy
3.
Transbound Emerg Dis ; 65(1): e135-e144, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28805020

ABSTRACT

Bovine viral diarrhoea virus (BVDV) infection in cattle can result in growth retardation, reduced milk production, reproductive disorders and death. Persistently infected animals are the primary source of infection. In Hokkaido, Japan, all cattle entering shared pastures in summer are vaccinated before movement for disease control. Additionally, these cattle may be tested for BVDV and culled if positive. However, the effectiveness of this control strategy aiming to reduce the number of BVDV-infected animals has not been assessed. The aim of this study was to evaluate the effectiveness of various test-and-cull and/or vaccination strategies on BVDV control in dairy farms in two districts of Hokkaido, Nemuro and Hiyama. A stochastic model was developed to compare the different control strategies over a 10-year period. The model was individual-based and simulated disease dynamics both within and between herds. Parameters included in the model were obtained from the literature, the Hokkaido government and the Japanese Ministry of Agriculture, Forestry and Fisheries. Nine different scenarios were compared as follows: no control, test-and-cull strategies based on antigen testing of either calves or only cattle entering common pastures, vaccination of all adult cattle or only cattle entering shared pastures and combinations thereof. The results indicate that current strategies for BVDV control in Hokkaido slightly reduced the number of BVDV-infected animals; however, alternative strategies such as testing all calves and culling any positives or vaccinating all susceptible adult animals dramatically reduced those. To our knowledge, this is the first report regarding the comparison of the effectiveness between the current strategies in Hokkaido and the alternative strategies for BVDV control measures.


Subject(s)
Bovine Virus Diarrhea-Mucosal Disease/prevention & control , Diarrhea Viruses, Bovine Viral/immunology , Models, Theoretical , Vaccination/veterinary , Animals , Bovine Virus Diarrhea-Mucosal Disease/epidemiology , Bovine Virus Diarrhea-Mucosal Disease/transmission , Bovine Virus Diarrhea-Mucosal Disease/virology , Cattle , Dairying , Diarrhea/veterinary , Diarrhea/virology , Female , Japan/epidemiology , Pregnancy
4.
Vet Pathol ; 52(3): 573-5, 2015 May.
Article in English | MEDLINE | ID: mdl-25047229

ABSTRACT

Cardiomyopathies have been rarely described in rabbits. Here we report myocardial necrosis of the ventricular wall in rabbits with experimentally induced rabies. Myocardial lesions were found only in rabbits with brain lesions, and the severity of the cardiac lesions was proportional to that of the brain lesions. Neither the frequency nor the cumulative dose of anesthesia was related to the incidence or the severity of the myocardial lesions. The myocardial lesions were characterized by degeneration and/or necrosis of myocardial cells and were accompanied by contraction band necrosis, interstitial fibrosis, and infiltration of inflammatory cells. The brain lesions due to rabies virus infection were most prominent in the cerebral cortex, thalamus, hypothalamus, brainstem, and medulla. Rabies virus antigen was not found in the hearts of any rabbits. Based on these findings, the myocardial lesions were classified as neurogenic cardiomyopathy.


Subject(s)
Cardiomyopathies/veterinary , Rabbits/virology , Rabies/veterinary , Animals , Brain/pathology , Brain Stem/pathology , Cardiomyopathies/etiology , Cardiomyopathies/pathology , Myocardium/pathology , Necrosis , Rabbits/anatomy & histology , Rabies/complications , Rabies/pathology , Rabies virus
5.
Vet Pathol ; 51(5): 919-31, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24165203

ABSTRACT

In an attempt to establish a primate model of chronic cadmium toxicosis, we ovariectomized cynomolgus monkeys and treated them with CdCl2 by repeated intravenous injections for 13 to 15 months. The animals showed normocytic-normochromic anemia. The cadmium treatment resulted in increases of urinary enzyme activity indicative of renal tubular degeneration. Histopathology of the kidney revealed renal proximal tubular atrophy accompanied by interstitial fibrosis. Decreased bone mineral density was evident in the trabecular and cortical zones of the lumbar vertebra and femur, with osteoid accumulation around the trabeculae and Haversian canals. Iron deposition at the mineralization front and osteoclasts hyperplasia were indicative of impairment of bone mineralization and an increase of resorption. Blood inorganic phosphorus and 1α,25(OH)2 vitamin D3 levels decreased and urinary deoxypyridinoline level increased in cadmium-treated animals. The renal and bone lesions closely resemble those of itai-itai disease patients, the most severe case of cadmium toxicosis in terms of clinical chemistry and histopathology. Thus, ovariectomized monkeys chronically exposed to cadmium can serve as a primate itai-itai disease model, which is beneficial for developing novel therapeutic methods, investigating the mechanisms of the renal and bone lesions, and establishing more clearly defined criteria for diagnosing the disease.


Subject(s)
Bone Diseases, Metabolic/chemically induced , Cadmium Poisoning/physiopathology , Cadmium/toxicity , Kidney Diseases/chemically induced , Monkey Diseases/chemically induced , Animals , Body Weight , Bone Density , Bone Diseases, Metabolic/physiopathology , Bone and Bones/physiopathology , Cadmium/analysis , Disease Models, Animal , Female , Femur/physiopathology , Kidney/physiopathology , Kidney Diseases/physiopathology , Liver/physiopathology , Macaca fascicularis , Monkey Diseases/physiopathology , Ovariectomy , Phosphorus/blood , Random Allocation , Urinalysis
6.
Tissue Antigens ; 83(1): 45-8, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24355007

ABSTRACT

A genetic polymorphism of the newly discovered interferon-λ 4 (IFNL4) gene was associated with hepatitis C virus (HCV) clearance in individuals of African ancestry. To assess whether a dinucleotide variant of IFNL4 (ss469415590) also affected treatment outcome of antiviral therapy in Japan, we genotyped 213 patients with chronic genotype 1 HCV infection and 176 healthy subjects. The ΔG allele was associated with treatment failure [odds ratio (OR) 4.73, P = 0.019], as was the IFL3 rs8099917 single nucleotide polymorphism (SNP) (OR 5.06, P = 0.068). The correlation between ss469415590 and rs8099917 was high (r(2) = 0.92, D' = 0.98). Multivariate analysis revealed that the rs8099917 SNP was independently associated with treatment failure (OR 5.28, P = 0.009). Therefore, ss469415590 may be another predictive marker of antiviral therapy outcome in the Japanese population.


Subject(s)
Hepatitis C, Chronic/genetics , Hepatitis C, Chronic/therapy , Interferon-alpha/therapeutic use , Interleukins/genetics , Ribavirin/therapeutic use , Adult , Aged , Aged, 80 and over , Female , Genotype , Hepatitis C, Chronic/diagnosis , Humans , Japan , Male , Middle Aged , Polymorphism, Genetic , Treatment Outcome , Young Adult
7.
Arch Toxicol ; 87(8): 1609-19, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23681119

ABSTRACT

The combined effects of various carcinogens found in food products are a concern for human health. In the present study, the effects of flumequine (FL) on the in vivo mutagenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in the liver were investigated. Additionally, we attempted to clarify the underlying mechanisms through comprehensive gene analysis using a cDNA microarray. Male gpt delta mice were fed a diet of 0.03 % MeIQx, 0.4 % FL, or 0.03 % MeIQx + 0.4 % FL for 13 weeks. The effects of cotreatment with phenobarbital (PB) were also examined. Treatment with MeIQx alone increased gpt and Spi(-) mutant frequencies, and cotreatment with FL, but not with PB, further exacerbated these effects, despite the lack of in vivo genotoxicity in mice treated with FL alone. FL caused an increase in Cyp1a2 mRNA levels and a decrease in Ugt1b1 mRNA levels, suggesting that the enhancing effects of FL may be due in part to modification of MeIQx metabolism by FL. Moreover, FL induced an increase in hepatocyte proliferation accompanied by hepatocellular injury. Increases in the mRNA levels of genes encoding cytokines derived from Kupffer cells, such as Il1b and Tnf, and cell cycle-related genes, such as Ccnd1 and Ccne1, suggested that FL treatment increases compensatory cell proliferation. Thus, the present study clearly demonstrated the combined effects of 2 different types of carcinogens known as contaminants in foods.


Subject(s)
Fluoroquinolones/toxicity , Liver/drug effects , Liver/pathology , Mutagens/toxicity , Quinoxalines/toxicity , Animals , Body Weight/drug effects , Cell Proliferation/drug effects , Cyclin D1/genetics , Cytochrome P-450 CYP1A2/genetics , Drug Synergism , Glucuronosyltransferase/genetics , Hepatocytes/drug effects , Liver/metabolism , Male , Mice , Mice, Transgenic , Mutation , Oligonucleotide Array Sequence Analysis , Phenobarbital/pharmacology
8.
Food Chem Toxicol ; 55: 476-83, 2013 May.
Article in English | MEDLINE | ID: mdl-23380203

ABSTRACT

Combined chronic toxicity and carcinogenicity studies of ozokerite (OZK), a natural wax substance used as a food additive for a gum base, were performed in male and female F344 rats. Dietary concentrations of 0%, 0.05%, 0.1% and 0.2% OZK were applied in a 52-week chronic toxicity study and 0%, 0.1% and 0.2% in a 104-week carcinogenicity study. In the chronic toxicity study, treatment with OZK caused a xenobiotic reaction against absorbed OZK, including formation of histiocytosis and granulomas with crystalline material in many organs in all of the treated males and females. Particularly in the liver, granulomatous inflammation was accompanied by hepatocellular vacuolation and changes in the serum biochemical parameters indicative of hepatic disorder. The number and area of glutathione S-transferase placental form (GST-P) positive foci were increased in all of the treated groups of both sexes, suggesting the proliferative effect of OZK. In the carcinogenicity study, the incidence of hepatocellular adenoma and the total tumor incidence in the liver of all of the treated males were significantly increased compared with the controls. In conclusion, long-term exposure to OZK caused systemic chronic inflammation due to a foreign body response. OZK was weakly carcinogenic in the liver of male F344 rats.


Subject(s)
Environmental Exposure , Waxes/toxicity , Animals , Carcinogenicity Tests , Female , Male , Organ Size/drug effects , Rats , Rats, Inbred F344 , Survival Rate
9.
Tissue Antigens ; 80(4): 305-16, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22861646

ABSTRACT

Current human leukocyte antigen (HLA) DNA typing methods such as the sequence-based typing (SBT) and sequence-specific oligonucleotide (SSO) methods generally yield ambiguous typing results because of oligonucleotide probe design limitations or phase ambiguity for HLA allele assignment. Here we describe the development and application of the super high-resolution single-molecule sequence-based typing (SS-SBT) of HLA loci at the 8-digit level using next generation sequencing (NGS). NGS which can determine an HLA allele sequence derived from a single DNA molecule is expected to solve the phase ambiguity problem. Eight classical HLA loci-specific polymerase chain reaction (PCR) primers were designed to amplify the entire gene sequences from the enhancer-promoter region to the 3' untranslated region. Phase ambiguities of HLA-A, -B, -C, -DRB1 and -DQB1 were completely resolved and unequivocally assigned without ambiguity to single HLA alleles. Therefore, the SS-SBT method described here is a superior and effective HLA DNA typing method to efficiently detect new HLA alleles and null alleles without ambiguity.


Subject(s)
Genetic Loci , HLA Antigens/analysis , High-Throughput Nucleotide Sequencing/methods , Multilocus Sequence Typing/methods , 3' Untranslated Regions , Alleles , DNA Primers , HLA Antigens/genetics , High-Throughput Nucleotide Sequencing/instrumentation , Humans , Multilocus Sequence Typing/instrumentation , Polymerase Chain Reaction , Promoter Regions, Genetic , Sequence Analysis, DNA
10.
Toxicology ; 290(2-3): 312-21, 2011 Dec 18.
Article in English | MEDLINE | ID: mdl-22024337

ABSTRACT

In order to investigate a medium-term animal model using reporter gene transgenic rodents in which general toxicity, genotoxicity and carcinogenicity are evaluated, F344 gpt delta rats were given a diet containing 0.1% and 0.5% (a carcinogenic dose) safrole for 13 weeks. Serum biochemistry and histopathological examinations revealed overt hepatotoxicity of safrole, in line with previous reports. In the current study, safrole treatment possibly resulted in renal toxicity in male rats. In the in vivo mutation assays, an increase or a tendency to increase of the gpt mutant frequencies (MFs) was observed in both sexes at the carcinogenic dose. The number and area of foci of glutathione S-transferase placental form (GST-P) positive hepatocytes, ratio of proliferating cell nuclear antigen (PCNA)-positive hepatocytes and 8-hydroxydeoxyguanosine (8-OHdG) levels in liver DNA were significantly increased in both sexes of the 0.5% group. The overall data suggested that the present model might be a promising candidate for investigating comprehensive toxicities of the agents. In addition, data demonstrating the base modification and cell proliferation due to exposure to safrole could contribute to understanding safrole-induced hepatocarcinogenesis, which imply expanding in application of this model.


Subject(s)
Chemical and Drug Induced Liver Injury/etiology , Disease Models, Animal , Escherichia coli Proteins/genetics , Pentosyltransferases/genetics , Safrole/toxicity , 8-Hydroxy-2'-Deoxyguanosine , Animals , Cell Proliferation/drug effects , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/metabolism , Dose-Response Relationship, Drug , Female , Glutathione Transferase/metabolism , Hepatocytes/drug effects , Hepatocytes/metabolism , Male , Mutagenicity Tests , Proliferating Cell Nuclear Antigen/metabolism , Rats , Rats, Inbred F344 , Rats, Transgenic , Safrole/administration & dosage , Sex Factors
11.
J Neurol Neurosurg Psychiatry ; 82(11): 1186-94, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21478205

ABSTRACT

BACKGROUND: Progression of silent brain infarctions (SBIs) and white-matter lesions (WMLs) seen on brain MRI is associated with an increased risk of cognitive impairment, but their relation to endothelial and inflammatory markers is unknown in type 2 diabetes mellitus. METHODS: In 190 type 2 diabetic outpatients (mean age 62.7 years), the authors related baseline levels of soluble intercellular adhesion molecule-1 (sICAM-1) and high-sensitivity C-reactive protein (hs-CRP) to subsequent brain MRI findings and cognitive function. The authors assessed incident SBIs and changes in periventricular and subcortical WMLs (PVWMLs and SCWMLs) on MRI performed at baseline and 3 and 6 years. Neuropsychological tests were administered to 83 patients older than 65 years at 6 years. This present study represents an extension of the authors' previously published study. RESULTS: SBIs were observed in 46 patients (24.2%), PVWMLs in 93 (48.9%) and SCWMLs in 87 (45.8%) on baseline MRI. After adjustment for age, gender, hypertension, duration of diabetes, baseline MRI findings and medication use, the relative odds associated with a 1SD increase in sICAM-1 levels at baseline were 1.67 (95% CI 1.02 to 3.05) for SBI progression and 2.17 (95% CI 1.29 to 3.62) for PVWML progression at 6 years. In contrast, baseline hs-CRP levels were significantly associated with SBI progression only at 3 years. Significant trends were observed between quartiles of sICAM-1 at baseline and scores in Digit Symbol substitution (p for trend=0.01). CONCLUSIONS: The findings suggest that higher sICAM-1 levels are associated with SBI and PVWML progression, and may predict impairment in psychomotor function in type 2 diabetes.


Subject(s)
Brain Ischemia/pathology , Cerebral Small Vessel Diseases/pathology , Diabetes Mellitus, Type 2/complications , Endothelium, Vascular/pathology , Aged , Brain/pathology , Cerebral Small Vessel Diseases/complications , Cognition Disorders/pathology , Diabetes Complications , Diabetes Mellitus, Type 2/pathology , Disease Progression , Female , Humans , Inflammation , Longitudinal Studies , Magnetic Resonance Imaging/methods , Male , Middle Aged
12.
Food Chem Toxicol ; 48(12): 3321-6, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20837086

ABSTRACT

A two year carcinogenicity study of anthelmintic drug levamisole (LV) was performed using 50 male and 50 female F344 rats at dietary drug concentrations of 0, 60, or 300 ppm. The daily intakes of LV were calculated to be 2.6, 12.9 mg/kg b.w./day for males and 2.9, 14.1mg/kg b.w./day for females, respectively. No significant differences in general condition and survival rate (82%, 74%, 80% in males and 84%, 84%, 84% in females, respectively) were observed. In the 300 ppm group, suppression of body weight gain was observed from the onset of treatment and reduction in final body weights was 6% in males and 11% in females. Significant increases in the absolute and/or relative weights of the lungs, heart, spleen, liver, kidneys, and adrenals were observed in males and/or females treated with 300 ppm. Some of high incidences neoplasms were observed, and there were also tendencies to increase for mammary gland fibroma and thoracic/abdominal cavity mesothelioma in males. However, there were no significant inter-group differences in incidences, histopathological types or differences compared with historical control data. Thus, it was concluded that LV was not carcinogenic to male and female F344 rats under the experimental conditions.


Subject(s)
Antinematodal Agents/toxicity , Carcinogens , Levamisole/toxicity , Animals , Body Weight/drug effects , Carcinogenicity Tests , Diet , Dose-Response Relationship, Drug , Eating , Female , Growth/drug effects , Male , Neoplasms/chemically induced , Neoplasms/pathology , Organ Size/drug effects , Rats , Rats, Inbred F344 , Survival
13.
Equine Vet J ; 42(6): 529-33, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20716193

ABSTRACT

REASONS FOR PERFORMING STUDY: Broad ligament haemorrhage in peripartum mares is a life-threatening disease and there are few reports on the aetiology and pathogenesis of broad ligament haematoma. OBJECTIVES: To obtain information regarding the sites for the early diagnosis and pathogenesis of broad ligament haematoma of mares. METHODS: Thirty-one mares that died of broad ligament haematoma peripartum were examined pathologically for bleeding sites. The arterial distribution of 5 young mares with several parities served as negative controls. RESULTS: Age and/or multiparity were the predisposing factors for the disease. Arterial injuries were most commonly observed in the uterine artery (24 of 31 mares). Among these, the proximal uterine artery that lies within 15 cm of the bifurcation of the iliac artery was the most frequent site for rupture (18 mares). The lesions occurred preferentially at the bifurcations, lateral part of curvatures and abrupt flexures of the artery. The morphology of the injuries was classified into 3 types: ruptures with and without longitudinal fissures, and transections. Histologically, the arterial wall adjacent to the rupture showed atrophy of smooth muscle cells with fibrosis of the tunica media and disruption and/or calcification of the internal elastic lamina. CONCLUSIONS: Arterial injuries that led to broad ligament haematoma in peripartum mares occurred most frequently in the proximal uterine artery, and atrophy of smooth muscle cells with fibrosis of the arterial wall was as one of the predisposing factors in aged and multiparous mares. POTENTIAL RELEVANCE: Monitoring small aneurysms, mural tearing, medial fibrosis at the proximal uterine artery by transrectal echography could provide useful information for the early diagnosis and possible prevention of broad ligament haematoma of peripartum mares.


Subject(s)
Broad Ligament/injuries , Hematoma/veterinary , Horse Diseases/pathology , Obstetric Labor Complications/veterinary , Animals , Female , Hematoma/pathology , Horses , Obstetric Labor Complications/pathology , Pregnancy , Uterine Artery/injuries , Uterine Artery/pathology , Uterus/blood supply
14.
Scand J Immunol ; 71(2): 109-14, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20384862

ABSTRACT

IgG4 has been implicated in a diverse set of complex pathologies - e.g. autoimmune pancreatitis (AIP), idiopathic membranous nephropathy - and carries unique features including lack of activation of the classical complement pathway and a dynamic Fab-arm exchange. We recently showed that the rheumatoid factor (RF)-like activity of IgG4 is achieved through a hitherto unknown, Fc-Fc (and not Fab-Fc as is the case in classical RF; CRF) interaction; hence the name, novel RF (NRF). Here, we further explore the resemblance/difference between CRF and NRF. As heterophilic interactions of human IgM RF (CRF) are well known, we checked whether this is the case for IgG4. Human IgG4 showed variable reactivity to animal IgGs: reacting intensely with rabbit and mouse IgGs, but weakly with others. The binding to rabbit IgG was not through the Fab (as in CRF) but via the Fc piece, as was recently shown for human IgG (NRF). This binding correlates with the IgG4 concentration per se and could therefore be of diagnostic usage and incidentally explain some observed interferences in biological assays. In conclusion, here is defined a novel heterophilic antibody interaction and is established the universality of the unique Fc-Fc binding, both involving IgG4.


Subject(s)
Antibodies, Heterophile/metabolism , Immunoglobulin Fc Fragments/metabolism , Immunoglobulin G/metabolism , Adult , Aged , Animals , Antibodies, Heterophile/chemistry , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin Fc Fragments/chemistry , Immunoglobulin G/chemistry , Male , Mice , Middle Aged , Pancreatitis, Chronic/metabolism , Protein Binding , Rabbits
15.
J Comp Pathol ; 141(4): 260-4, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19592008

ABSTRACT

An adult swan goose (Anser cygnoides) kept in a zoological garden had gross hepatic enlargement with extensive ill-defined white foci. Microscopically, the hepatic lesions were composed of a mixture of adipocytes and myeloid cells. The goose was also affected with systemic amyloidosis and there were areas of osseous metaplasia associated with deposition of amyloid within the liver.


Subject(s)
Amyloidosis/veterinary , Bird Diseases/pathology , Liver Diseases/veterinary , Liver Neoplasms/veterinary , Liver/pathology , Myelolipoma/veterinary , Amyloidosis/complications , Amyloidosis/pathology , Animals , Cell Proliferation , Female , Geese , Liver Diseases/complications , Liver Diseases/pathology , Liver Neoplasms/complications , Liver Neoplasms/pathology , Metaplasia/complications , Metaplasia/pathology , Metaplasia/veterinary , Myelolipoma/complications , Myelolipoma/pathology
16.
Vet Pathol ; 45(5): 685-9, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18725474

ABSTRACT

A 2-year-old, male Japanese native fowl (Gallus gallus domesticus) was presented with an inability to feed and torticollis. At a necropsy, there were cylindrical enlargements and yellow discoloration of multiple peripheral nerves, including nerves of the lumbosacral plexus, brachial plexus, and spinal ganglia. On histologic examination, these lesions consisted of diffuse proliferations of spindle cells with characteristic onion bulb-like structures around residual axons. The spindle cells were immunohistochemically positive for glucose transporter 1 (GLUT1) and negative for S-100 alpha/beta proteins. On the basis of microscopic, histologic, and immunohistochemical findings, the tumors were diagnosed as multiple perineuriomas.


Subject(s)
Chickens , Nerve Sheath Neoplasms/veterinary , Poultry Diseases/pathology , Animals , Avian Leukosis/pathology , Avian Leukosis/virology , Avian Leukosis Virus/genetics , Avian Leukosis Virus/growth & development , Fatal Outcome , Immunohistochemistry/veterinary , Male , Nerve Sheath Neoplasms/pathology , Nerve Sheath Neoplasms/virology , Poultry Diseases/virology , RNA, Viral/chemistry , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction/veterinary
17.
Food Chem Toxicol ; 46(8): 2689-93, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18539379

ABSTRACT

Combined chronic toxicity and carcinogenicity studies of paprika color, used as a food additive in various countries, were performed in male and female F344 rats. Dietary concentrations of 0%, 0.62%, 1.25%, 2.5% and 5% were applied in a 52-week toxicity study and 0%, 2.5% and 5% in a 104-week carcinogenicity study. Treatment with paprika color caused a significant increase in incidence of hepatocellular vacuolation in 5% males, but no toxicological effects were found with reference to survival rates, body weights, hematological or serum biochemical parameters and organ weights at any dose level in either sex in the chronic toxicity study. Also, paprika color did not induce specific tumors nor did it exert significant influence on the development of spontaneous tumors in any of the organs examined in the carcinogenicity study. In conclusion, based on slight histopathological changes observed in 5% male livers, the no-observed-effect level (NOEL) was estimated to be 2.5% in the diet (1,253 mg/kg bw/day) and the no-observed-adverse-effect level (NOAEL) was determined to be 5% in the diet (2,388 mg/kg bw/day) for male rats, and for females, the NOEL was concluded to be 5% in the diet (2,826 mg/kg bw/day). Additionally, paprika color was not carcinogenic to male and female F344 rats under the present experimental conditions.


Subject(s)
Capsicum/toxicity , Carcinogens , Food Coloring Agents/toxicity , Animals , Blood Cell Count , Blood Chemical Analysis , Body Weight/drug effects , Carcinogenicity Tests , Diet , Eating/drug effects , Female , Male , Organ Size/drug effects , Plant Extracts/toxicity , Rats , Rats, Inbred F344 , Survival Analysis
18.
Food Chem Toxicol ; 46(3): 1119-24, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18155344

ABSTRACT

Ellagic acid is a phenolic acid compound, used as a food additive for its antioxidative properties. Because of its chemical characteristics, use is also to be expected in cosmetics. The present 90-day subchronic toxicity study was performed in F344 rats at dose levels of 0, 1.25, 2.5 and 5% in powdered basal diet, with actual doses of 9.4, 19.1, 39.1 g/kg b.w., respectively, in males, and 10.1, 20.1, 42.3 g/kg b.w. in females. No mortality or treatment-related clinical signs were observed throughout the experimental period. Body weight gain was significantly reduced from weeks 3 (5% group), 6 (2.5% group) and 7 (1.25% group) to the end of the experiment (except week 8 in the lowest group) in the treated females, the final body weights being decreased in the 5% (92.5%), 2.5% (94.2%) and 1.25% (94.8%) treated groups as compared to the control. Changes in MCV and serum AST, ALP, Ca, Cl and P were sporadically observed, but these were not considered to be treatment-related alterations. There were no obvious histopathological changes in any of the groups. The no-observed-effect level (NOEL) was estimated to be 5% (3011 mg/kg b.w./day) for males and the no-observed-adverse-effect level (NOAEL) and NOEL in females were estimated to be 5% (3254 mg/kg b.w./day) and <1.25% (778 mg/kg b.w./day), respectively.


Subject(s)
Antioxidants/toxicity , Ellagic Acid/toxicity , Food Additives/toxicity , Animals , Blood Chemical Analysis , Body Weight/drug effects , Feeding Behavior/drug effects , Female , Hematologic Tests , Male , No-Observed-Adverse-Effect Level , Organ Size/drug effects , Rats , Rats, Inbred F344
20.
J Viral Hepat ; 14(1): 48-54, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17212644

ABSTRACT

We sought to clarify the incidence and role of Helicobacter pylori (H. pylori) seropositivity in patients with hepatitis C virus (HCV) infection and the effect of coinfection on interferon-alpha and ribavirin therapy. The presence of H. pylori was tested using a commercially available enzyme immunoassay in serum samples from 93 patients with chronic hepatitis C. Clinical features, HCV markers and response of HCV to interferon-alpha and ribavirin were compared between H. pylori-positive and H. pylori-negative patients. Anti-H. pylori antibody was detected in 45 (48%) of the 93 patients, whose median HCV-RNA level (495 vs 760 kIU/mL; P = 0.013) and platelet count (128 vs 158 x 10(3)/microL; P = 0.009) were significantly lower than in patients with HCV infection alone. Anti-H. pylori antibody levels were found to be significantly correlated with fibrosis score (P = 0.0083, r = 0.33) but inversely related to platelet count (P = 0.0037, r = -0.34). The sustained response rate for HCV clearance following interferon-alpha and ribavirin treatment did not differ between patients with and without anti-H. pylori seropositivity. The presence of H. pylori [odds ratio (OR) 8.61; 95% confidence interval (CI) 1.59-46.70] and fibrosis score (OR 30.13; 95% CI 5.44-166.78) were found by multivariate analysis to be associated with the decrease of platelet count during therapy. Coexistent H. pylori infection does not demonstrably influence the clinical course of chronic hepatitis C. A possible connection between H. pylori coinfection and thrombocytopenia was found during the treatment course, suggesting that preemptive eradication of H. pylori may facilitate completion of treatment and increased sustained virological response.


Subject(s)
Antiviral Agents/therapeutic use , Helicobacter Infections/complications , Helicobacter Infections/virology , Helicobacter pylori/growth & development , Hepacivirus/growth & development , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/microbiology , Interferon-alpha/therapeutic use , Ribavirin/therapeutic use , Adult , Aged , Alanine Transaminase/blood , Drug Therapy, Combination , Female , Helicobacter Infections/microbiology , Hepatitis C, Chronic/virology , Humans , Interferon alpha-2 , Male , Middle Aged , Multivariate Analysis , Platelet Count , RNA, Viral/blood , Recombinant Proteins , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...